• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 - 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Comparison by End-user
o Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024
o Academic and research institutes - Market size and forecast 2019-2024
o Others - Market size and forecast 2019-2024
o Market opportunity by End user
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2019-2024
o Europe - Market size and forecast 2019-2024
o Asia - Market size and forecast 2019-2024
o ROW - Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Avra Synthesis Pvt. Ltd.
o bioMérieux SA
o Bio-Rad Laboratories Inc.
o Eiken Chemical Co. Ltd.
o HiMedia Laboratories Pvt. Ltd.
o Merck KGaA
o Neogen Chemicals Ltd.
o SCHARLAB SL
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2019 - 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 - 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2019
• 21: End user - Market share 2019-2024 (%)
• 22: Comparison by End user
• 23: Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024 ($ million)
• 24: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2024 (%)
• 25: Academic and research institutes - Market size and forecast 2019-2024 ($ million)
• 26: Academic and research institutes - Year-over-year growth 2019-2024 (%)
• 27: Others - Market size and forecast 2019-2024 ($ million)
• 28: Others - Year-over-year growth 2019-2024 (%)
• 29: Market opportunity by End user
• 30: Customer landscape
• 31: Market share by geography 2019-2024 (%)
• 32: Geographic comparison
• 33: North America - Market size and forecast 2019-2024 ($ million)
• 34: North America - Year-over-year growth 2019-2024 (%)
• 35: Europe - Market size and forecast 2019-2024 ($ million)
• 36: Europe - Year-over-year growth 2019-2024 (%)
• 37: Asia - Market size and forecast 2019-2024 ($ million)
• 38: Asia - Year-over-year growth 2019-2024 (%)
• 39: ROW - Market size and forecast 2019-2024 ($ million)
• 40: ROW - Year-over-year growth 2019-2024 (%)
• 41: Key leading countries
• 42: Market opportunity by geography ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Avra Synthesis Pvt. Ltd. - Overview
• 50: Avra Synthesis Pvt. Ltd. - Product and service
• 51: Avra Synthesis Pvt. Ltd. - Key offerings
• 52: Avra Synthesis Pvt. Ltd. - Key customers
• 53: Avra Synthesis Pvt. Ltd. - Segment focus
• 54: Becton, Dickinson and Co. - Overview
• 55: Becton, Dickinson and Co. - Business segments
• 56: Becton, Dickinson and Co. - Key offerings
• 57: Becton, Dickinson and Co. - Key customers
• 58: Becton, Dickinson and Co. - Segment focus
• 59: bioMérieux SA - Overview
• 60: bioMérieux SA - Business segments
• 61: bioMérieux SA - Key offerings
• 62: bioMérieux SA - Key customers
• 63: bioMérieux SA - Segment focus
• 64: Bio-Rad Laboratories Inc. - Overview
• 65: Bio-Rad Laboratories Inc. - Business segments
• 66: Bio-Rad Laboratories Inc. - Key offerings
• 67: Bio-Rad Laboratories Inc. - Key customers
• 68: Bio-Rad Laboratories Inc. - Segment focus
• 69: Eiken Chemical Co. Ltd. - Overview
• 70: Eiken Chemical Co. Ltd. - Business segments
• 71: Eiken Chemical Co. Ltd. - Key offerings
• 72: Eiken Chemical Co. Ltd. - Key customers
• 73: Eiken Chemical Co. Ltd. - Segment focus
• 74: HiMedia Laboratories Pvt. Ltd. - Overview
• 75: HiMedia Laboratories Pvt. Ltd. - Product and service
• 76: HiMedia Laboratories Pvt. Ltd. - Key offerings
• 77: HiMedia Laboratories Pvt. Ltd. - Key customers
• 78: HiMedia Laboratories Pvt. Ltd. - Segment focus
• 79: Merck KGaA - Overview
• 80: Merck KGaA - Business segments
• 81: Merck KGaA - Key offerings
• 82: Merck KGaA - Key customers
• 83: Merck KGaA - Segment focus
• 84: Neogen Chemicals Ltd. - Overview
• 85: Neogen Chemicals Ltd. - Product and service
• 86: Neogen Chemicals Ltd. - Key offerings
• 87: Neogen Chemicals Ltd. - Key customers
• 88: Neogen Chemicals Ltd. - Segment focus
• 89: SCHARLAB SL - Overview
• 90: SCHARLAB SL - Product and service
• 91: SCHARLAB SL - Key offerings
• 92: SCHARLAB SL - Key customers
• 93: SCHARLAB SL - Segment focus
• 94: Thermo Fisher Scientific Inc. - Overview
• 95: Thermo Fisher Scientific Inc. - Business segments
• 96: Thermo Fisher Scientific Inc. - Key offerings
• 97: Thermo Fisher Scientific Inc. - Key customers
• 98: Thermo Fisher Scientific Inc. - Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations

Companies Mentioned
. Avra Synthesis Pvt. Ltd.
. Becton
. Dickinson and Co.
. bioMérieux SA
. Bio-Rad Laboratories Inc.
. Eiken Chemical Co. Ltd.
. HiMedia Laboratories Pvt. Ltd.
. Merck KGaA
. Neogen Chemicals Ltd.
. SCHARLAB SL 
. Thermo Fisher Scientific Inc.